These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 27085460

  • 1. Induction of integrin β3 by sustained ERK activity promotes the invasiveness of TGFβ-induced mesenchymal tumor cells.
    Hong SK, Park JR, Kwon OS, Kim KT, Bae GY, Cha HJ.
    Cancer Lett; 2016 Jul 01; 376(2):339-46. PubMed ID: 27085460
    [Abstract] [Full Text] [Related]

  • 2. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
    Kim YJ, Choi WI, Jeon BN, Choi KC, Kim K, Kim TJ, Ham J, Jang HJ, Kang KS, Ko H.
    Toxicology; 2014 Aug 01; 322():23-33. PubMed ID: 24793912
    [Abstract] [Full Text] [Related]

  • 3. Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells.
    Galliher AJ, Schiemann WP.
    Breast Cancer Res; 2006 Aug 01; 8(4):R42. PubMed ID: 16859511
    [Abstract] [Full Text] [Related]

  • 4. Targeted inactivation of β1 integrin induces β3 integrin switching, which drives breast cancer metastasis by TGF-β.
    Parvani JG, Galliher-Beckley AJ, Schiemann BJ, Schiemann WP.
    Mol Biol Cell; 2013 Nov 01; 24(21):3449-59. PubMed ID: 24006485
    [Abstract] [Full Text] [Related]

  • 5. Integrin β3 Mediates the Endothelial-to-Mesenchymal Transition via the Notch Pathway.
    Wang W, Wang Z, Tian D, Zeng X, Liu Y, Fu Q, Liang A, Zhang Y, Gao Q, Cheng J, Wang Y.
    Cell Physiol Biochem; 2018 Nov 01; 49(3):985. PubMed ID: 30196283
    [Abstract] [Full Text] [Related]

  • 6. Loss of TAK1 increases cell traction force in a ROS-dependent manner to drive epithelial-mesenchymal transition of cancer cells.
    Lam CR, Tan C, Teo Z, Tay CY, Phua T, Wu YL, Cai PQ, Tan LP, Chen X, Zhu P, Tan NS.
    Cell Death Dis; 2013 Oct 10; 4(10):e848. PubMed ID: 24113182
    [Abstract] [Full Text] [Related]

  • 7. Chronic TGFβ stimulation promotes the metastatic potential of lung cancer cells by Snail protein stabilization through integrin β3-Akt-GSK3β signaling.
    Bae GY, Hong SK, Park JR, Kwon OS, Kim KT, Koo J, Oh E, Cha HJ.
    Oncotarget; 2016 May 03; 7(18):25366-76. PubMed ID: 27015122
    [Abstract] [Full Text] [Related]

  • 8. Implication of epithelial-mesenchymal transition in IGF1R-induced resistance to EGFR-TKIs in advanced non-small cell lung cancer.
    Zhou J, Wang J, Zeng Y, Zhang X, Hu Q, Zheng J, Chen B, Xie B, Zhang WM.
    Oncotarget; 2015 Dec 29; 6(42):44332-45. PubMed ID: 26554308
    [Abstract] [Full Text] [Related]

  • 9. Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin β3-p38 MAPK signalling.
    Wen S, Hou Y, Fu L, Xi L, Yang D, Zhao M, Qin Y, Sun K, Teng Y, Liu M.
    Cancer Lett; 2019 Feb 01; 442():320-332. PubMed ID: 30391782
    [Abstract] [Full Text] [Related]

  • 10. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
    Wang H, Zhang H, Tang L, Chen H, Wu C, Zhao M, Yang Y, Chen X, Liu G.
    Toxicology; 2013 Jan 07; 303():139-46. PubMed ID: 23146760
    [Abstract] [Full Text] [Related]

  • 11. P21 activated kinase-1 mediates transforming growth factor β1-induced prostate cancer cell epithelial to mesenchymal transition.
    Al-Azayzih A, Gao F, Somanath PR.
    Biochim Biophys Acta; 2015 May 07; 1853(5):1229-39. PubMed ID: 25746720
    [Abstract] [Full Text] [Related]

  • 12. Transglutaminase-2 induces N-cadherin expression in TGF-β1-induced epithelial mesenchymal transition via c-Jun-N-terminal kinase activation by protein phosphatase 2A down-regulation.
    Park MK, You HJ, Lee HJ, Kang JH, Oh SH, Kim SY, Lee CH.
    Eur J Cancer; 2013 May 07; 49(7):1692-705. PubMed ID: 23290789
    [Abstract] [Full Text] [Related]

  • 13. Sanguiin H6 suppresses TGF-β induction of the epithelial-mesenchymal transition and inhibits migration and invasion in A549 lung cancer.
    Ko H, Jeon H, Lee D, Choi HK, Kang KS, Choi KC.
    Bioorg Med Chem Lett; 2015 Dec 01; 25(23):5508-13. PubMed ID: 26508552
    [Abstract] [Full Text] [Related]

  • 14. The EDA-containing cellular fibronectin induces epithelial-mesenchymal transition in lung cancer cells through integrin α9β1-mediated activation of PI3-K/AKT and Erk1/2.
    Sun X, Fa P, Cui Z, Xia Y, Sun L, Li Z, Tang A, Gui Y, Cai Z.
    Carcinogenesis; 2014 Jan 01; 35(1):184-91. PubMed ID: 23929437
    [Abstract] [Full Text] [Related]

  • 15. MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer.
    Menezes ME, Shen XN, Das SK, Emdad L, Sarkar D, Fisher PB.
    Oncotarget; 2016 Dec 06; 7(49):80175-80189. PubMed ID: 27863394
    [Abstract] [Full Text] [Related]

  • 16. Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells.
    Li L, Qi L, Liang Z, Song W, Liu Y, Wang Y, Sun B, Zhang B, Cao W.
    Int J Mol Med; 2015 Jul 06; 36(1):113-22. PubMed ID: 26005723
    [Abstract] [Full Text] [Related]

  • 17. Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation.
    Ellenrieder V, Hendler SF, Boeck W, Seufferlein T, Menke A, Ruhland C, Adler G, Gress TM.
    Cancer Res; 2001 May 15; 61(10):4222-8. PubMed ID: 11358848
    [Abstract] [Full Text] [Related]

  • 18. ERK1/2 blockade prevents epithelial-mesenchymal transition in lung cancer cells and promotes their sensitivity to EGFR inhibition.
    Buonato JM, Lazzara MJ.
    Cancer Res; 2014 Jan 01; 74(1):309-19. PubMed ID: 24108744
    [Abstract] [Full Text] [Related]

  • 19. Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC).
    Zhao Q, Yue J, Zhang C, Gu X, Chen H, Xu L.
    Oncotarget; 2015 Oct 06; 6(30):29335-46. PubMed ID: 26336823
    [Abstract] [Full Text] [Related]

  • 20. TGFβ1 induces endometrial cancer cell adhesion and migration by up-regulating integrin αvβ3 via SMAD-independent MEK-ERK1/2 signaling.
    Xiong S, Klausen C, Cheng JC, Leung PCK.
    Cell Signal; 2017 Jun 06; 34():92-101. PubMed ID: 28336232
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.